Stay updated with breaking news from Myron zitt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
December 16, 2020 The updated guidelines recommend patients currently using separate inhalers for daily asthma control and asthma attack relief now use one combination inhaler in both cases. Karl Francis Dale Tapales/Getty Images; iStock Two groups within the National Institutes of Health the National Asthma Education and Prevention Program (NAEPP) and the National Heart, Lung, and Blood Institute (NHLBI) updated their asthma management guidelines in December. This update is the first one since 2007 and several topics were due for review. The guidelines were published in December in One significant change will affect adults and children ages 4 or older with moderate to severe persistent asthma who are using daily controller inhalers. According to the updated guideline, people in this group should now use a single inhaler containing both an inhaled corticosteroid and a bronchodilator daily as a preventive medication and for quick relief during an asthma attack. ....
Those administering COVID vaccine should be trained in use of EpiPen | Opinion Updated Dec 17, 2020; Posted Dec 17, 2020 Valerie Bolcar, a registered nurse at the Morristown, N.J., Medical Center, prepares to administer the COVID-19 vaccine to frontline workers on Tuesday. Patti Sapone | NJ Advance Media Facebook Share By Robert K. Houton The COVID-19 vaccination that began rolling out this week to frontline medical workers will hopefully end our long nightmare with this virus and the pandemic. But there is one concern: 1.6% of the American population, or roughly 5 million people, have experienced a severe allergic attack, called anaphylaxis, and may have a severe reaction to the vaccine. ....
Those who give the COVID-19 vaccine need to be trained to use an EpiPen | Opinion Updated Dec 15, 2020; Posted Dec 15, 2020 About 1.6% of the American population, or roughly 5 million people, have experienced a severe allergic attack, called anaphylaxis, and may have a severe reaction to the vaccine. Robert K. Houton, founder of the Training Epinephrine Administrators in Medication (TEAM) Association, is working with the FDA to get those who administer the vaccine training in using EpiPens.(AP Photo/Mark Lennihan, Pool)AP Facebook Share By Robert K. Houton The COVID-19 vaccination that began rolling out this week to frontline medical workers will hopefully end our long nightmare with this virus and the pandemic. But there is one concern: 1.6% of the American population, or roughly 5 million people, have experienced a severe allergic attack, called anaphylaxis, and may have a severe reaction to the vaccine. ....